In all of these experiments an improvement of the principal symptoms of diabetes have been also revealed in CoPP treated animals, indicating that the increased expression of HO-1 induced by this treatment is the principal responsible for their neuroprotective effects in diabetic animals. This evidence concerns the gene HMOX1 and diabetes mellitus.